141 related articles for article (PubMed ID: 32558016)
1. Insight Into Myocardial Microstructure of Athletes and Hypertrophic Cardiomyopathy Patients Using Diffusion Tensor Imaging.
Das A; Chowdhary A; Kelly C; Teh I; Stoeck CT; Kozerke S; Maxwell N; Craven TP; Jex NJ; Saunderson CED; Brown LAE; Ben-Arzi H; Sengupta A; Page SP; Swoboda PP; Greenwood JP; Schneider JE; Plein S; Dall'Armellina E
J Magn Reson Imaging; 2021 Jan; 53(1):73-82. PubMed ID: 32558016
[TBL] [Abstract][Full Text] [Related]
2. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E
Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy: a comparison of motion-compensated spin echo and stimulated echo techniques.
Khalique Z; Scott AD; Ferreira PF; Nielles-Vallespin S; Firmin DN; Pennell DJ
MAGMA; 2020 Jun; 33(3):331-342. PubMed ID: 31758419
[TBL] [Abstract][Full Text] [Related]
4. In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.
Ferreira PF; Kilner PJ; McGill LA; Nielles-Vallespin S; Scott AD; Ho SY; McCarthy KP; Haba MM; Ismail TF; Gatehouse PD; de Silva R; Lyon AR; Prasad SK; Firmin DN; Pennell DJ
J Cardiovasc Magn Reson; 2014 Nov; 16(1):87. PubMed ID: 25388867
[TBL] [Abstract][Full Text] [Related]
5. Acute Microstructural Changes after ST-Segment Elevation Myocardial Infarction Assessed with Diffusion Tensor Imaging.
Das A; Kelly C; Teh I; Stoeck CT; Kozerke S; Chowdhary A; Brown LAE; Saunderson CED; Craven TP; Chew PG; Jex N; Swoboda PP; Levelt E; Greenwood JP; Schneider JE; Plein S; Dall'Armellina E
Radiology; 2021 Apr; 299(1):86-96. PubMed ID: 33560187
[TBL] [Abstract][Full Text] [Related]
6. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
[TBL] [Abstract][Full Text] [Related]
7. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance.
Nielles-Vallespin S; Khalique Z; Ferreira PF; de Silva R; Scott AD; Kilner P; McGill LA; Giannakidis A; Gatehouse PD; Ennis D; Aliotta E; Al-Khalil M; Kellman P; Mazilu D; Balaban RS; Firmin DN; Arai AE; Pennell DJ
J Am Coll Cardiol; 2017 Feb; 69(6):661-676. PubMed ID: 28183509
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
McGill LA; Ismail TF; Nielles-Vallespin S; Ferreira P; Scott AD; Roughton M; Kilner PJ; Ho SY; McCarthy KP; Gatehouse PD; de Silva R; Speier P; Feiweier T; Mekkaoui C; Sosnovik DE; Prasad SK; Firmin DN; Pennell DJ
J Cardiovasc Magn Reson; 2012 Dec; 14(1):86. PubMed ID: 23259835
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy or athlete's heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters.
Bakogiannis C; Mouselimis D; Tsarouchas A; Papatheodorou E; Vassilikos VP; Androulakis E
Eur J Sport Sci; 2023 Jan; 23(1):143-154. PubMed ID: 34720041
[TBL] [Abstract][Full Text] [Related]
11. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy.
Kübler J; Burgstahler C; Brendel JM; Gassenmaier S; Hagen F; Klingel K; Olthof SC; Blume K; Wolfarth B; Mueller KAL; Greulich S; Krumm P
Int J Cardiovasc Imaging; 2021 Aug; 37(8):2501-2515. PubMed ID: 34019206
[TBL] [Abstract][Full Text] [Related]
12. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
[TBL] [Abstract][Full Text] [Related]
14. Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM.
Gastl M; Lachmann V; Christidi A; Janzarik N; Veulemans V; Haberkorn S; Holzbach L; Jacoby C; Schnackenburg B; Berrisch-Rahmel S; Zeus T; Kelm M; Bönner F
Eur Radiol; 2021 May; 31(5):2768-2777. PubMed ID: 33063183
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis.
D'Andrea A; Caso P; Bossone E; Scarafile R; Riegler L; Di Salvo G; Gravino R; Cocchia R; Castaldo F; Salerno G; Golia E; Limongelli G; De Corato G; Cuomo S; Pacileo G; Russo MG; Calabrò R
Eur J Echocardiogr; 2010 Jul; 11(6):492-500. PubMed ID: 20551250
[TBL] [Abstract][Full Text] [Related]
16. Assessment of left atrial function in hypertrophic cardiomyopathy and athlete's heart: a left atrial myocardial deformation study.
Gabrielli L; Enríquez A; Córdova S; Yáñez F; Godoy I; Corbalán R
Echocardiography; 2012 Sep; 29(8):943-9. PubMed ID: 22954405
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of human patellar tendon microstructure and microcirculation with diffusion MRI.
Wengler K; Fukuda T; Tank D; Komatsu DE; Paulus M; Huang M; Gould ES; Schweitzer ME; He X
J Magn Reson Imaging; 2020 Mar; 51(3):780-790. PubMed ID: 31407413
[TBL] [Abstract][Full Text] [Related]
19. An in-vivo comparison of stimulated-echo and motion compensated spin-echo sequences for 3 T diffusion tensor cardiovascular magnetic resonance at multiple cardiac phases.
Scott AD; Nielles-Vallespin S; Ferreira PF; Khalique Z; Gatehouse PD; Kilner P; Pennell DJ; Firmin DN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):1. PubMed ID: 29298692
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
